Matthew T. Gillespie
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Melphalan modifies the bone microenvironment by enhancing osteoclast formation.
Journal: Oncotarget
Published: January 05, 2017
Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia major.
Journal: Internal medicine journal
Published: October 15, 2016
Bone Disease in Thalassemia: A Molecular and Clinical Overview.
Journal: Endocrine reviews
Published: June 17, 2016
Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuria.
Journal: Bone
Published: November 19, 2015
Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 15, 2015
RARγ is a negative regulator of osteoclastogenesis.
Journal: The Journal of steroid biochemistry and molecular biology
Published: December 01, 2014
Osteoclast formation elicited by interleukin-33 stimulation is dependent upon the type of osteoclast progenitor.
Journal: Molecular and cellular endocrinology
Published: June 17, 2014
Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
Journal: The Journal of biological chemistry
Published: April 03, 2014
Thalassemia bone disease: a 19-year longitudinal analysis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: February 16, 2014
The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses.
Journal: Blood
Published: February 12, 2014
The effect of gonadal status on body composition and bone mineral density in transfusion-dependent thalassemia.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: April 10, 2013
HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
Journal: The Biochemical journal
Published: February 06, 2013
Last Updated: 09/26/2026